BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1343894)

  • 1. Vaccine strategies against schistosomiasis.
    Capron A; Dessaint JP; Capron M; Pierce RJ
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 4():19-27. PubMed ID: 1343894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccine strategies against schistosomiasis.
    Capron A; Dessaint JP; Capron M; Pierce RJ
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 5():1-9. PubMed ID: 1342702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a vaccine strategy against human and bovine schistosomiasis. Background and update.
    Capron A; Riveau G; Grzych JM; Boulanger D; Capron M; Pierce R
    Trop Geogr Med; 1994; 46(4 Spec No):242-6. PubMed ID: 7825228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic aspects of schistosomiasis.
    Capron A; Dessaint JP
    Annu Rev Med; 1992; 43():209-18. PubMed ID: 1580585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a vaccine strategy against human and bovine schistosomiasis. Background and update.
    Capron A; Riveau G; Grzych JM; Boulanger D; Capron M; Pierce R
    Mem Inst Oswaldo Cruz; 1995; 90(2):235-40. PubMed ID: 8531664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effector functions of eosinophils in schistosomiasis.
    Capron M; Capron A
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 4():167-70. PubMed ID: 1343889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective immunity induced in rat schistosomiasis by a single dose of the Sm28GST recombinant antigen: effector mechanisms involving IgE and IgA antibodies.
    Grezel D; Capron M; Grzych JM; Fontaine J; Lecocq JP; Capron A
    Eur J Immunol; 1993 Feb; 23(2):454-60. PubMed ID: 8436179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Schistosoma mansoni ex vivo lung-stage larvae excretory-secretory antigens as vaccine candidates against schistosomiasis.
    El Ridi R; Tallima H
    Vaccine; 2009 Jan; 27(5):666-73. PubMed ID: 19056448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunity to schistosomes: progress toward vaccine.
    Capron A; Dessaint JP; Capron M; Ouma JH; Butterworth AE
    Science; 1987 Nov; 238(4830):1065-72. PubMed ID: 3317823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of antibody dependent cell mediated cytotoxicity (ADCC) in Sm-p80-mediated protection against Schistosoma mansoni.
    Torben W; Ahmad G; Zhang W; Nash S; Le L; Karmakar S; Siddiqui AA
    Vaccine; 2012 Nov; 30(48):6753-8. PubMed ID: 23000221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effects of anti-antiidiotypic IgE antibodies obtained from an IgE monoclonal antibody specific for a 26-kilodalton Schistosoma mansoni antigen.
    Velge-Roussel F; Verwaerde C; Grzych JM; Auriault A; Capron A
    J Immunol; 1989 Apr; 142(7):2527-32. PubMed ID: 2494262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional analysis of a T cell line specific for antiidiotypic antibodies to a Schistosoma mansoni protective epitope. II. Induction of protective immunity in experimental rat schistosomiasis.
    Velge-Roussel F; Auriault C; Damonneville M; Capron A
    J Immunol; 1991 Dec; 147(11):3967-72. PubMed ID: 1719096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human antibody responses to Schistosoma mansoni: does antigen directed, isotype restriction result in the production of blocking antibodies?
    Dunne DW; Fulford AJ; Butterworth AE; Koech D; Ouma JH
    Mem Inst Oswaldo Cruz; 1987; 82 Suppl 4():101-4. PubMed ID: 3151083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenicity and immunogenicity of a multiple peptidic construction of the Schistosoma mansoni Sm-28 GST antigen in rat, mouse, and monkey. 1. Partial protection of Fischer rat after active immunization.
    Wolowczuk I; Auriault C; Bossus M; Boulanger D; Gras-Masse H; Mazingue C; Pierce RJ; Grezel D; Reid GD; Tartar A
    J Immunol; 1991 Mar; 146(6):1987-95. PubMed ID: 1900878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgE declares war on parasites.
    Thompson C
    Lancet; 1994 Feb; 343(8893):309-10. PubMed ID: 7905141
    [No Abstract]   [Full Text] [Related]  

  • 16. Functional properties of a rat monoclonal IgE antibody specific for Schistosoma mansoni.
    Verwaerde C; Joseph M; Capron M; Pierce RJ; Damonneville M; Velge F; Auriault C; Capron A
    J Immunol; 1987 Jun; 138(12):4441-6. PubMed ID: 3108390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against experimental Schistosoma mansoni schistosomiasis achieved by immunization with schistosomula released products antigens (SRP-A): role of IgE antibodies.
    Damonneville M; Auriault C; Verwaerde C; Delanoye A; Pierce R; Capron A
    Clin Exp Immunol; 1986 Aug; 65(2):244-52. PubMed ID: 3098476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A purified 28,000 dalton protein from Schistosoma mansoni adult worms protects rats and mice against experimental schistosomiasis.
    Balloul JM; Grzych JM; Pierce RJ; Capron A
    J Immunol; 1987 May; 138(10):3448-53. PubMed ID: 3106483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization against Egyptian Schistosoma mansoni infection by multivalent DNA vaccine.
    Romeih MH; Hassan HM; Shousha TS; Saber MA
    Acta Biochim Biophys Sin (Shanghai); 2008 Apr; 40(4):327-38. PubMed ID: 18401531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human IgE responses to Schistosoma mansoni and resistance to reinfection.
    Dunne DW; Butterworth AE; Fulford AJ; Ouma JH; Sturrock RF
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 4():99-103. PubMed ID: 1343933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.